PharmEasy to raise Rs 2,400 cr, Manipal Group likely to invest Rs 1,000 cr

- Best Investment Advisor in India
- Business
- Commodity Market
- Currency
- Equity Market
- FII based calls
- Foreign Markets
- Genuine stock tips provider
- Intraday trading tips
- Intraday trading tips & Strategies
- Investment adviser
- Investments
- IT Industry
- Most accurate stock tips provider
- News
- NSE F&O
- Operator based calls
- Politics
- Portfolio Management Services
- promotions
- SEBI Registered advisory company
- Stock Market
Online pharmacy firm PharmEasy is expected to raise Rs 2,400 crore through a rights issue at a 90 percent discount to help pay back its loan from Goldman Sachs, The Economic Times (ET) reported on Wednesday. The company has informed its board and investors of the decision.
A rights issue is undertaken to allow shareholders to acquire additional shares of a company.
The report added that PharmEasy parent, API Holdings, will issue new stock at Rs 5 per share in its rights issue. At its peak, the company had raised funds at Rs 50 per share.
TPG and Temasek are in charge of the rights issue, and Ranjan Pai, chairman of the Manipal group, is expected to join the company’s board.
According to a separate report by Moneycontrol, Manipal Group will lead the round and invest nearly Rs 1,000 crore for an 18 percent stake in the firm. It added that API Holdings has kept the shares of Thyrocare, another company it owns, as collateral for the debt.
PharmEasy has outstanding debt of around Rs 2,400 crore.
If the rights issue is successful, it will be one of the first major down rounds for a big internet firm through new financing. A person aware of the matter was quoted in the ET report as saying that the rights issue will most likely take place at a valuation of $500-600 million.
It was last valued at $5.6 billion in 2021.
The report also said that the price of the share had to be adjusted as it was freely available in the grey market for Rs 20.
According to earlier reports, PharmEasy had violated a key loan term imposed by Goldman Sachs by failing to close a Rs 1,000 crore funding round.
“Following the convent breach, the board and shareholders demanded that the loan be repaid to Goldman Sachs,” said a person familiar with the developments told ET.
The company could opt for an outright distress sale or a rights issue, which would allow current investors to buy more at a lower cost.
PharmEasy withdrew its plans to launch an initial public offer (IPO) last year. At one point, its share price was as high as Rs 130. But now, the markets have turned sour on new-age startup stocks.
ET report also said that while crossover funds and public market investors have reduced the value of their stakes in Indian tech startups, a down round via fresh fundraising has yet to hit the domestic ecosystem.
#1 stock adviser in India Accurate stock tips provider Best Equity Portfolio Management Best Intraday calls provider Best Intraday Tips Best Intraday tips provider Best Investment adviser in India Best Portfolio Management services Best Portfolio Management services in India Best SEBI registered investment advisor Best SEBI registered stock advisory company Best Share Market intraday tips Best stock advisor websites Best stock advisory company in India Best stock tips provider in india Best tips provider in India Genuine Account Management services Genuine SEBI registered advisory company Genuine stock market tips provider India no 1 stock advisory company India’s top rated advisory company India’s top rated Stock tips provider Intraday calls in stock future Intraday calls in stock market Intraday Jackpot tips Intraday Sureshot tips Intraday Sureshot tips provider Intraday tips Intraday tips in F&O Intraday trading in share market Intraday trading techniques Intraday trading tips Intraday trading tips & Strategies Intraday trading tips in stock market Investment adviser Jackpot intraday tips Most accurate investment adviser in India Most successful stock advisors in india Operator based calls Operator based intraday stock tips Operator based intraday tips Operator based options tips Operator based sureshot calls Share market trading tips online Stock market Stock market news Stock Market tips Stock market trading tips provider Strategy for Wealth Management and Financial planning Top rated Portfolio Management services Top rated SEBI registered stock advisory firms
Archives
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- March 2023
- February 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
Categories
- Best Investment Advisor in India
- Business
- Commodity Market
- Currency
- Equity Market
- FII based calls
- Foreign Markets
- Genuine stock tips provider
- Intraday trading tips
- Intraday trading tips & Strategies
- Investment adviser
- Investments
- IT Industry
- Most accurate stock tips provider
- News
- NSE F&O
- Operator based calls
- Politics
- Portfolio Management Services
- promotions
- SEBI Registered advisory company
- Stock Market
- Uncategorized
Calender
M | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | 2 | |||||
3 | 4 | 5 | 6 | 7 | 8 | 9 |
10 | 11 | 12 | 13 | 14 | 15 | 16 |
17 | 18 | 19 | 20 | 21 | 22 | 23 |
24 | 25 | 26 | 27 | 28 |